Type 2 Diabetes: Symptoms, Diagnosis, and Management

Type 2 diabetes is the most common form of diabetes, accounting for around 90% of all cases worldwide. It develops when the body becomes resistant to insulin or stops producing enough of it, leading to a sustained rise in blood glucose. This guide brings together what current UK and international guidelines — NICE NG28, the NHS, the ADA Standards of Care, and Diabetes UK — recommend for diagnosis, monitoring, and day-to-day management.

This is a living guide. Each linked article below covers a specific aspect in more depth.

What is type 2 diabetes?

Type 2 diabetes is a chronic condition in which the body cannot use insulin effectively (insulin resistance) and the pancreas eventually struggles to keep up with demand. Over time this leads to chronically elevated blood glucose, which can damage blood vessels, nerves, eyes, kidneys, and heart.

It is distinct from type 1 diabetes, which is an autoimmune condition where the pancreas stops producing insulin altogether. Type 2 diabetes is closely linked to weight, physical inactivity, family history, and ethnicity — but it can also occur in people who are not overweight.

Symptoms and diagnosis

Common symptoms include excessive thirst, frequent urination, unexplained tiredness, blurred vision, slow wound healing, and recurrent infections. Many people, however, have no symptoms for years.

Diagnosis is confirmed by:

HbA1c ≥ 48 mmol/mol (6.5%) on two separate occasions, or
Fasting plasma glucose ≥ 7.0 mmol/L (126 mg/dL), or
Random plasma glucose ≥ 11.1 mmol/L (200 mg/dL) with symptoms, or
2-hour OGTT ≥ 11.1 mmol/L

An HbA1c of 42–47 mmol/mol (6.0–6.4%) indicates non-diabetic hyperglycaemia (prediabetes) — a state of high risk for progression to type 2 diabetes that can often be reversed with lifestyle change.

Who is at risk?

Age 40+ (or 25+ if from a South Asian, Black African, or African-Caribbean background)
Family history of type 2 diabetes (parent, sibling, or child)
Overweight or obesity, particularly with central (abdominal) fat
Physical inactivity
History of gestational diabetes or polycystic ovary syndrome (PCOS)
High blood pressure or abnormal cholesterol
Sleep apnoea

How type 2 diabetes is managed

Management has three pillars: lifestyle, monitoring, and (when needed) medication.

Lifestyle

Diet: Reducing refined carbohydrates and ultra-processed foods, prioritising vegetables, lean protein, and healthy fats. Both Mediterranean and low-carbohydrate dietary patterns have strong evidence for type 2 diabetes.
Physical activity: NICE recommends at least 150 minutes of moderate-intensity activity per week, plus muscle-strengthening twice weekly. Resistance training in particular is shown to improve insulin sensitivity.
Weight management: Even modest weight loss (5–10%) can dramatically improve glycaemic control. Larger losses can put type 2 diabetes into remission in some people, especially within the first 6 years of diagnosis.
Sleep and stress: Chronic poor sleep and high stress raise cortisol, worsening insulin resistance.

Monitoring

HbA1c — every 3–6 months until stable, then 6–12 monthly. Most adults have an individualised target of 48–53 mmol/mol (6.5–7.0%).
Self-monitoring of blood glucose — usually only required if on insulin or sulfonylureas, or during illness, pregnancy, or treatment changes.
Annual reviews covering blood pressure, lipids, kidney function (eGFR + ACR), foot examination, and retinal screening.

Medication

NICE NG28 recommends a stepwise approach. Metformin remains first-line for most adults. The next step depends on cardiovascular and renal risk:

SGLT2 inhibitors (e.g. empagliflozin, dapagliflozin) — preferred when there is established cardiovascular disease, heart failure, or chronic kidney disease.
GLP-1 receptor agonists (e.g. semaglutide, dulaglutide, tirzepatide as a dual GIP/GLP-1) — strong glycaemic and weight effects, increasingly used earlier in care.
DPP-4 inhibitors, sulfonylureas, pioglitazone — additional options based on individual factors.
Insulin — added when oral and injectable non-insulin therapies are insufficient.

Frequently asked questions

Can type 2 diabetes be reversed?

Yes — though clinicians prefer the term remission, defined as an HbA1c below 48 mmol/mol (6.5%) sustained for at least three months without glucose-lowering medication. The DiRECT trial showed that a structured low-calorie diet leading to 10–15 kg weight loss put type 2 diabetes into remission in nearly half of participants within the first 6 years of diagnosis.

What’s the difference between type 1 and type 2 diabetes?

Type 1 is an autoimmune condition where the pancreas no longer produces insulin — it always requires insulin replacement. Type 2 starts with insulin resistance, often manageable for years through lifestyle and oral medication, though some people eventually need insulin too.

Do I need to test my blood sugar daily?

Most people with type 2 diabetes who are not on insulin or sulfonylureas do not need daily home glucose testing — HbA1c every 3–6 months gives a clearer picture. NICE specifically advises against routine self-monitoring in non-insulin-treated type 2 diabetes unless there is a specific reason.

Is type 2 diabetes hereditary?

Family history is a strong risk factor — having a parent or sibling with type 2 diabetes roughly doubles your risk. But genes interact heavily with lifestyle: people with strong family history can often delay or prevent type 2 diabetes through diet, activity, and weight management.

What HbA1c target should I aim for?

NICE recommends individualised targets — typically 48 mmol/mol (6.5%) for adults managed by diet or a single medication, and 53 mmol/mol (7.0%) for those on a medication carrying a hypoglycaemia risk. Older adults or those with frailty often have higher targets to reduce hypoglycaemia risk. Discuss your personal target with your diabetes team.

Reviewed against NICE NG28 and the ADA Standards of Care 2026. Last reviewed: May 2026.

Spread the love